Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.

CONCLUSIONS: Data are insufficient to promote the use of intravenous midazolam infusion as a sedative for neonates undergoing intensive care. This review raises concerns about the safety of midazolam in neonates. Further research on the effectiveness and safety of midazolam in neonates is needed.
PMID: 28141899 [PubMed - in process]

Source: Cochrane Database of Systematic Reviews - January 30, 2017 Category: Journals (General) Authors: Ng E, Taddio A, Ohlsson A Tags: Cochrane Database Syst Rev Source Type: research